CLINICAL APPLICATION OF END SYSTOLIC P-V RELATIONS
CLINICAL APPLICATION OF END SYSTOLIC P-V RELATIONS
批准号:
6183249
负责人:
MARK R STARLING
金额:
$24.51万
依托单位国家:
美国
项目类别:
财政年份:
1985
资助国家:
美国
项目状态:
已结题
起止时间:
1985-09-30 至 2002-03-31
关键词:
ACE inhibitors angiotensin II atrial natriuretic peptide beta adrenergic receptor cardiac output clinical research gene expression heart catheterization heart conduction system heart contraction heart function heart metabolism heart pharmacology heart surgery heart valve disorder heart ventriculography human subject intracardiac volume mitral valve radiotracer renin angiotensin system sympathetic nervous system
中文摘要
这项研究提案的长期目标是确定一个时间
慢性左心室容量超负荷的外科治疗
主动脉瓣关闭不全(AR)或二尖瓣关闭不全(MR)
恢复正常的LV大小和性能。LV体积的自然历史
超负荷遵循一个潜在的可识别的血流动力学过程
以代偿性左室肥厚为特征,其次为左室收缩
在没有心肌功能障碍的情况下,最后,
不可逆转的心肌功能障碍。临床上常用的、非
有创、有创和有创指标倾向于识别AR和MR晚期患者
在其血流动力学过程中不可逆性心肌功能不全时
占主导地位。相比之下,这个实验室的初步数据
有力地支持了这一假说,即左心室收缩功能不全的缺失
AR和MR患者的心肌功能障碍可以通过
同时应用最大时变弹性和心肌刚度
概念,在这种情况下的左心室收缩功能障碍是
不充分的左室肥厚和球状几何假设,以及
此时对左心室容量过载的手术将逆转这些不利因素
血流动力学过程,从而保存或恢复正常的左心室大小和
性能。因此,这项研究建议的具体目的是:
1)用来表征LV腔性能和心肌特性
正常人的时变弹性和心肌硬度概念
患者,并与AR或MR患者进行对比;2)
建立LV腔弹性异常的发生机制
3)建立AR患者亚群
或MR根据有无或正常的LV室壁弹性和
心肌性质;4)确定改变的程度和时间进程
在AR和MR手术后一年的左心室大小和表现,
5)评价手术对AR和MR的独立影响
左心室弹性和心肌特性。这项研究建议
因此,代表了复杂的血液动力学的独特组合
集成的方法专注于提供新数据来定义
无心肌梗死患者左心室收缩功能障碍的机制
AR和MR患者的功能障碍和手术保留时间
或恢复正常的LV大小和性能。
英文摘要
The long-term goal of this research proposal is to define a time for
surgery in chronic left ventricular (LV) volume overload resulting from
aortic regurgitation (AR) or mitral regurgitation (MR) to preserve or
restore normal LV size and performance. The natural history of LV volume
overload follows a potentially identifiable hemodynamic course
characterized by compensated LV hypertrophy, followed by LV systolic
dysfunction in the absence of myocardial dysfunction, and finally,
irreversible myocardial dysfunction. The commonly employed clinical, non-
invasive, and invasive indices tend to identify patient with AR and MR late
in their hemodynamic course when irreversible myocardial dysfunction
predominates. In contrast, the preliminary data from this laboratory
strongly support the hypotheses that LV systolic dysfunction in the absence
of myocardial dysfunction can be identified in patients with AR and MR by
applying both the maximum time-varying elastance and myocardial stiffness
concepts, that LV systolic dysfunction in this setting is the result of
inadequate LV hypertrophy and assumption of spherical geometry, and that
surgery for LV volume overload at this time will reverse these detrimental
hemodynamic processes and, thereby, preserve or restore normal LV size and
performance. Therefore, the specific aims of this research proposal are:
1) to characterize LV chamber performance and myocardial properties using
the time-varying elastance and myocardial stiffness concepts in normal
patients and contrast them with those in patients with AR or MR; 2) to
establish mechanisms for abnormal LV chamber elastance in the presence of
normal myocardial properties; 3) to establish subgroups of patients with AR
or MR based upon the presence or absence or normal LV chamber elastance and
myocardial properties; 4) to define the extent and time course of changes
in LV size and performance during the year following surgery for AR and MR,
and 5) to characterize the independent effects of surgery for AR and MR on
LV chamber elastance and myocardial properties. This research proposal
represents, therefore, a unique combination of sophisticated hemodynamic
approaches that are integrated to focus on providing new data to define the
mechanisms for LV systolic dysfunction in the absence of myocardial
dysfunction and a time for surgery in patients with AR and MR to preserve
or restore normal LV size and performance.
期刊论文(35)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Radionuclide determination of the relationship between left ventricular contractile state and ejection fraction.
放射性核素测定左心室收缩状态与射血分数的关系。
DOI:
10.1016/0002-8703(88)90339-0
发表时间:
1988
期刊:
American heart journal
影响因子:
4.8
作者:
[Starling,MR, Gross,MD, Walsh,RA, Mancini,GB, Blumhardt,R]
通讯作者:
Blumhardt,R
Assessment of right ventricular oxidative metabolism by positron emission tomography with C-11 acetate in aortic valve disease.
使用 C-11 醋酸盐进行正电子发射断层扫描评估主动脉瓣疾病中的右心室氧化代谢。
DOI:
10.1016/0002-9149(91)90535-s
发表时间:
1991
期刊:
The American journal of cardiology
影响因子:
--
作者:
[Hicks,RJ, Kalff,V, Savas,V, Starling,MR, Schwaiger,M]
通讯作者:
Schwaiger,M
Dissociation of end systole from end ejection in patients with long-term mitral regurgitation.
长期二尖瓣反流患者收缩末期与射血末期的分离。
DOI:
10.1161/01.cir.81.4.1277
发表时间:
1990
期刊:
Circulation
影响因子:
37.8
作者:
[Brickner,ME, Starling,MR]
通讯作者:
Starling,MR
Relation between maximum time-varying elastance pressure-volume areas and myocardial oxygen consumption in dogs.
狗最大时变弹性压力-体积面积与心肌耗氧量之间的关系。
DOI:
10.1161/01.cir.83.1.304
发表时间:
1991
期刊:
Circulation
影响因子:
37.8
作者:
[Starling,MR, Mancini,GB, Montgomery,DG, Gross,MD]
通讯作者:
Gross,MD
Responsiveness of the maximum time-varying elastance to alterations in left ventricular contractile state in man.
最大时变弹性对人类左心室收缩状态变化的响应。
DOI:
10.1016/0002-8703(89)90019-7
发表时间:
1989
期刊:
American heart journal
影响因子:
4.8
作者:
[Starling,MR]
通讯作者:
Starling,MR
共 22 条
EFFECT OF AMLODIPINE ON SURVIVAL IN PATIENTS WITH CONGESTIVE HEART FAILURE
-
批准号:6113468
-
项目类别:
-
资助金额:$0.02万
-
财政年份:1998
-
负责人:MARK R STARLING
-
依托单位:
EFFECT OF AMLODIPINE ON SURVIVAL IN PATIENTS WITH CONGESTIVE HEART FAILURE
-
批准号:6297197
-
项目类别:
-
资助金额:$0.02万
-
财政年份:1998
-
负责人:MARK R STARLING
-
依托单位:
CLINICAL APPLICATION OF END SYSTOLIC P-V RELATIONS
-
批准号:6297077
-
项目类别:
-
资助金额:$0.02万
-
财政年份:1998
-
负责人:MARK R STARLING
-
依托单位:
CLINICAL APPLICATION OF END SYSTOLIC P-V RELATIONS
-
批准号:6113343
-
项目类别:
-
资助金额:$0.02万
-
财政年份:1998
-
负责人:MARK R STARLING
-
依托单位:
CLINICAL APPLICATION OF END SYSTOLIC P-V RELATIONS
-
批准号:6244518
-
项目类别:
-
资助金额:$2.22万
-
财政年份:1997
-
负责人:MARK R STARLING
-
依托单位:
CLINICAL APPLICATION OF END SYSTOLIC P-V RELATIONS
-
批准号:6274577
-
项目类别:
-
资助金额:$2.15万
-
财政年份:1997
-
负责人:MARK R STARLING
-
依托单位:
EFFECT OF AMLODIPINE ON SURVIVAL IN PATIENTS WITH CONGESTIVE HEART FAILURE
-
批准号:6274702
-
项目类别:
-
资助金额:$2.15万
-
财政年份:1997
-
负责人:MARK R STARLING
-
依托单位:
PRAISE 2--EFFECT OF AMLODIPINE ON SURVIVAL IN PTS W/ CONGESTIVE HEART FAILURE
-
批准号:6244687
-
项目类别:
-
资助金额:$2.22万
-
财政年份:1997
-
负责人:MARK R STARLING
-
依托单位:
Multidiscplinary Cardiovascular Research Training
-
批准号:6453990
-
项目类别:
-
资助金额:$37.18万
-
财政年份:1996
-
负责人:MARK R STARLING
-
依托单位:
Multidiscplinary Cardiovascular Research Training
-
批准号:6612690
-
项目类别:
-
资助金额:$38.69万
-
财政年份:1996
-
负责人:MARK R STARLING
-
依托单位:
TRAINING IN MOLECULAR AND CELLULAR CARDIOLOGY
-
批准号:6139086
-
项目类别:
-
资助金额:$16.71万
-
财政年份:1996
-
负责人:MARK R STARLING
-
依托单位:
CLINICAL APPLICATION OF END-SYSTOLIC P-V RELATIONS
-
批准号:3074062
-
项目类别:
-
资助金额:$2.16万
-
财政年份:1985
-
负责人:MARK R STARLING
-
依托单位:
CLINICAL APPLICATION OF END-SYSTOLIC P-V RELATIONS
-
批准号:3351496
-
项目类别:
-
资助金额:$20.82万
-
财政年份:1985
-
负责人:MARK R STARLING
-
依托单位:
CLINICAL APPLICATION OF END-SYSTOLIC P-V RELATIONS
-
批准号:3351492
-
项目类别:
-
资助金额:$12.73万
-
财政年份:1985
-
负责人:MARK R STARLING
-
依托单位:
CLINICAL APPLICATION OF END SYSTOLIC P-V RELATIONS
-
批准号:2028247
-
项目类别:
-
资助金额:$23.14万
-
财政年份:1985
-
负责人:MARK R STARLING
-
依托单位:
CLINICAL APPLICATION OF END-SYSTOLIC P-V RELATIONS
-
批准号:3074061
-
项目类别:
-
资助金额:$5.18万
-
财政年份:1985
-
负责人:MARK R STARLING
-
依托单位:
CLINICAL APPLICATION OF END-SYSTOLIC P-V RELATIONS
-
批准号:3074060
-
项目类别:
-
资助金额:$5.18万
-
财政年份:1985
-
负责人:MARK R STARLING
-
依托单位:
CLINICAL APPLICATION OF END-SYSTOLIC P-V RELATIONS
-
批准号:3073778
-
项目类别:
-
资助金额:$3.2万
-
财政年份:1985
-
负责人:MARK R STARLING
-
依托单位:
CLINICAL APPLICATION OF END-SYSTOLIC P-V RELATIONS
-
批准号:3074059
-
项目类别:
-
资助金额:$5.16万
-
财政年份:1985
-
负责人:MARK R STARLING
-
依托单位:
CLINICAL APPLICATION OF END-SYSTOLIC P-V RELATIONS
-
批准号:3074058
-
项目类别:
-
资助金额:$5.18万
-
财政年份:1985
-
负责人:MARK R STARLING
-
依托单位:
海外基金